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Prostate carcinomaAbstract Purpose: Our aim was to investigate the diffusion-weighted Imaging (DWI) appearance
and apparent diffusion coefﬁcient (ADC) values of normal prostatic gland, prostate carcinoma
(PCa) and benign prostate hyperplasia (BPH) and to determine the utility of DWI in their charac-
terization.
Materials and methods: During a period of 16 months, 40 consecutive patients, with elevated PSA
level and 12 healthy volunteers with no clinical symptoms or history of prostate disease were pro-
spectively evaluated with DWI of the prostate. MRI was performed using a 1.5T MR scanner
equipped with a pelvic phased array coil. For anatomical imaging, T2W FSE in the three orthog-
onal planes, and T1WI in axial plane were obtained. DWI with b values of 0, 300, 500 and 800 s/
mm2 were performed in axial plane. The results were conﬁrmed by TRUS-guided biopsy or
prostatectomy.
Results: Patients ranged in age from 45 to 85 years (mean 66.6 ± 7.9 year). Twenty patients were
conﬁrmed to have BPH, whereas 20 patients had PCa. The mean and SD of ADC values for the
peripheral zone (PZ), central gland (CG), BPH nodules and PCa were 1.839 ± 0.233,
1.469 ± 0.239, 1.359 ± 0.201 and 0.87 ± 0.13 respectively. The mean ADC value of PCa was sig-
niﬁcantly lower than that of CG, PZ, and BPH nodule, with p value <0.05.
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DWI with ADC may be used as a complementary method to conventional MRI in diagnosis of
PCa and BPH.
 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Radiology and Nuclear
Medicine. Open access under CC BY-NC-ND license.1. Introduction
Benign prostatic hyperplasia (BPH) and prostate carcinoma
(PCa) are the most common diseases of the prostate. During
the past several years, their morbidities have increased sharply
all over the world. Therefore, early diagnosis and differential
diagnosis of prostatic diseases have caught the attention of
physicians. Many imaging methods have been widely used in
the diagnosis of prostatic diseases (1).
MRI has been considered as an excellent technique for detec-
tion of prostatic carcinoma (2). High-spatial-resolution T2-
weighted rapid acquisition with a small ﬁeld of view, performed
with endorectal and/or external body phased-array coils, is gen-
erally used to depict prostate anatomy. On T2-weighted images,
prostate cancer appears as an area of low signal intensity within
the high signal intensity of a normal peripheral zone (3).
However, anatomic T2-weighted MR imaging has limited
diagnostic value in discriminating prostate cancer from benign
prostate tissue, as focal areas of low signal intensity in the
peripheral zone do not always represent cancer (4).
Benign abnormalities such as chronic prostatitis, atrophy,
scars, post-irradiation or hormonal treatment effects, hyper-
plasia, and post biopsy hemorrhage may mimic tumor tissue
(5). Furthermore, 30% of tumours that occur in the central
gland cannot be detected on T2 weighted imaging because it
is not possible to differentiate them from the low signal-inten-
sity benign nodules of prostatic hyperplasia (6).
Of all functional MR imaging techniques diffusion-
weighted imaging (DWI) is the most practical and simple in
its use (3). It has the advantages of not requiring IV contrast
material and of being simple to process. Moreover, DWI re-
quires less time to acquire than proton MR spectroscopy
and less technologist training to perform (7). However it has
the disadvantages of being susceptible to motion and to mag-
netic ﬁeld inhomogeneities (3).
DW imaging has been shown to aid in distinguishing be-
tween malignant and benign prostate tissue based on relatively
lower apparent diffusion coefﬁcients (ADCs) of cancer tissue
(5,8). The extensive branching ductal structure of the normal
prostate compared with the highly restricted intracellular and
interstitial spaces encountered in prostate cancers produces a
substantial differential in apparent diffusion coefﬁcient
(ADC), and thus the potential for high image contrast (6).
Our aim was investigating the DWI appearance and ADC
values of normal prostatic gland, prostate carcinoma (PCa)
and benign prostate hyperplasia (BPH) and to determine the
utility of DWI in their characterization.
2. Materials and methods
2.1. Patients
During a period of 16 months duration from June 2012 to Sep-
tember 2013, 40 consecutive patients, with elevated PSA leveland 12 healthy volunteers with no clinical symptoms or history
of prostate disease were prospectively evaluated with MRI
diffusion of the prostate. This study was performed after the
approval of the scientiﬁc and ethics committee of the
hospital. Informed consents were obtained from patients and
volunteers.
The patients presented with dysuria, frequent micturition,
urgency, weak stream and retention of urine or gross
hematuria. TRUS was done to all patients prior to MRI
examination, whereas TRUS-guided biopsy was done to 10
patients before MRI examination. The rest of the patients
underwent MRI examination followed by TRUS guided
biopsy. The time interval ranges between MRI and biopsy
from 20 days to 1 month. No patient had a history of pelvic
irradiation, thermal, hormonal therapy to the prostate or
chemotherapy.
The results of MRI were conﬁrmed by TRUS-guided
biopsy or prostatectomy. Ten BPH patients were subjected
to trans-urethral resection of the prostate (TURP) whereas 7
underwent open prostatectomies, 3 received medical treatment.
Among the 20 prostate cancer patients, 13 patients underwent
radical prostatectomy, 1 patient underwent both radical pro-
statectomy and orchiectomy while 2 patients received external
beam radiation therapy following orchiectomy, and 4 patients
received radiation therapy.
2.2. MR imaging
The MRI examinations were performed using a 1.5-Tesla MR
scanner (Gyroscan Intera, Philips medical systems, Nether-
lands). MRI examinations were obtained with body coil in su-
pine position. For anatomical imaging of the prostate T2
weighted fast spin-echo (FSE) in the three orthogonal planes,
axial, sagittal and coronal planes were obtained with the fol-
lowing parameters:[TR/effective TE] 2000/90 ms, echo train
length 16, number of signal average (NSA) 2. FOV 14 cm2,
acquisition matrix 256 · 512, number of contiguous slices 20,
slice thickness 3 mm and interslice gap 0.5 mm.
T1-weighted turbo spin-echo (TSE) in axial plane was ob-
tained with the following parameters: TR/TE 400/10 ms,
NSA 2, FOV 14 cm2, matrix 256 · 150, number of contiguous
slices 20, slice thickness 3 mm; interslice gap 0.5 mm; acquisi-
tion time 4 min.
Echo-planar diffusion-weighted sequences with b values
of 0, 500 and 800 s/mm2 were performed in the axial plane
with orientation and location identical to those performed
for the axial T2-weighted anatomic images. Spin-echo
echo-planar imaging (EPI) sequence with a pair of rectangu-
lar gradient pulses along with three orthogonal axes was ob-
tained with the following parameters: TR/TE:3600/110 ms,
echo train length 16, number of signal average (NSA) 2,
FOV 14 cm2, acquisition matrix 256 · 512, number of con-
tiguous slices 20, slice thickness 3 mm and inter-slice gap
0.5 mm.
Table 1 Demographic data of the patients.
Age PSA level (ng/mL)
BPH 66.5 years ± 8.6 (48–80) 13.53
PCa 67.1 years ± 6.9 (55–85) 60.41
Fig. 1 Normal prostate. (a) Axial T2 WI of prostate gland
showing normal prostate parenchyma with hyper-intense PZ. (b)
Diffusion WI showing the normal homogenous signal of the CG
and PZ. (c) ADC map: The calculated mean ADC value of the PZ
is 1.917 · 103 mm2/s. The calculated mean ADC value of the CG
is 1.304 · 103 mm2/s.
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The locations, contour and edges of the lesions on T2WI were
evaluated. Analysis of diffusion images was performed
qualitatively by means of visual assessment of signal intensity
on images acquired at high b values and their corresponding
ADC maps and quantitatively by means of ADC
measurements.
Prostate cancer was deﬁned as a lesion with focal or diffuse
hypo-intensity on T2WI with corresponding hyperintensity on
DWI and low value on ADC map compared to the rest of the
gland. BPH was deﬁned as central gland nodule with heteroge-
neous high or low signal intensity.
In cases of prostate cancer, invasion of the neurovascular
bundles, breaching of the prostatic capsule, involvement of
the seminal vesicles were evaluated, together with the presence
of metastatic pelvic lymph nodes and bone deposits of the pel-
vic bones.
2.4. ADC calculation
DWI datasets were transferred to an independent workstation
(Philips MR extended workspace, software version 2009).
ADC maps were calculated automatically with the MRI sys-
tem and ADC values were expressed in square millimeters
per second.
The DWI images, including the images obtained with b val-
ues of 0, 500, and 800 s/mm2, were reviewed together. ADCs
were measured from each lesion for b 800 s/mm2 by using
ROIs (regions of interest). The size of ROIs was chosen to
be as large as possible and with minimal contamination from
normal tissue. At least three measurements were performed
and the least value was recorded. Circular ROIs were placed
in the normal central and peripheral zones of the normal
individuals.
The ADC values of BPH and PCa lesions were compared
with the histological results of prostatectomy and biopsy
specimen.
We also compared the performance of T2 weighted
MRI alone versus T2 combined with DWI in localization of
PCa.
3. Statistical analysis
Statistical analysis was performed with SPSS (Statistical Pack-
age for the Social Sciences) V21. ADC values were deﬁned as
mean ± standard deviation. An independent sample t-test was
conducted to examine whether there was a signiﬁcant differ-
ence between ADC value of normal peripheral zone (PZ), nor-
mal central gland (CG), BPH nodules and prostate carcinoma.
The differences in the ADC values were considered to be sta-
tistically signiﬁcant when the p value was <0.05.
4. Results
The 40 patients enrolled in this study were ranging in age from
45 to 85 years (mean age 66.6 ± 7.9 year). Twenty patients
were conﬁrmed to have BPH, whereas 20 patients had prostate
cancer. Demographic data of the patients are demonstrated in
Table 1.
Fig. 2 BPH in 68-year old male, PSA level 12.2 ng/mL. (a) Axial
T2 WI of the prostate showing enlarged heterogeneous CG with
compressed PZ. (b) Diffusion WI showing no areas of diffusion
restriction. (c) ADC map showing non-uniform signal intensity of
the CG, the calculated ADC value of the CG is 1.12 · 103 mm2/s,
the calculated ADC value of the PZ is 1.35 · 103 mm2/s.
Fig. 3 PCa in 70-year old male, PSA level 30.7 ng/mL, Gleason
score 2 + 3. (a) Axial T2 WI of the prostate showing small
hypointense lesion in the left side of the PZ. (b and c) Diffusion
WI and ADC map showing restricted diffusion of the lesion, with
the ADC value is 0.98 · 103 mm2/s.
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The CG and PZ of normal prostate were easily discriminated
on diffusion and ADC images (Fig. 1). The signal intensity
of BPH nodule was non-homogeneous and lower than that
of PZ on ADC map (Fig. 2). PCa showed high signal intensity
on DWI and low signal intensity on ADC map (Figs. 3 and 4).
The ADC value was obtained from all volunteers and pa-
tients. The mean and standard deviation (SD) ADC valuesfor the CG, normal PZ, BPH nodules and prostate carcinomas
are presented in Table 2 for volunteers and patients.
The mean ADC value of prostate carcinoma was
signiﬁcantly lower than that of normal CG, PZ, and BPH
nodule (q value < 0.05). The PZ tissue had a signiﬁcantly
higher ADC value than CG (p< 0.05). The ADC value
of BPH lesions was signiﬁcantly lower than that of CG
(p< 0.05).
For localization of prostate cancers, the accuracy, sensitiv-
ity and speciﬁcity for combined T2 and diffusion were 90%,
Fig. 4 PCa in 65-year old male, with PSA level 53.9 ng/mL, Gleason score 4 + 3. (a) Axial T2 WI of the prostate showing large
hypointense lesion, extending beyond the capsule on the right side, with involvement of the right NVB. (b and c) Diffusion WI and ADC
map showing restricted diffusion of the lesion. The ADC value is 0.76 · 103 mm2/s. (d and e) Diffusion WI and ADC map showing
restricted diffusion of the metastatic lymph nodes. The ADC value is 0.72 · 103 mm2/s.
Table 2 Mean ADC values (mean ± SD) with b value of 800 s/mm2 for normal peripheral zone (PZ), normal central gland (CG),
BPH nodule and prostate carcinoma.
Tissue Normal Pz Normal CG PCa BPH
ADC (·103 mm2) 1.839 ± 0.233 (1.5–2.2) 1.469 ± 0.239 (1.3–1.8) 0.87 ± 0.13 (0.6–1.17) 1.359 ± 0.201 (0.8–1.58)
N 12 12 20 20
N: number. SD: standard deviation.
DWI and ADC measurement in prostate carcinoma 53985% and 95% respectively compared to 77.5%, 65% and 90%
when using T2 alone.
The (TNM) staging of the primary tumor ranged from T1
to T4, with 2 patients staged as T1, 8 patients as T2, 7 patientsas T3 whereas the other 3 patients as T4 (Table 3). Six patients
showed nodal metastasis (N1). Six patients showed bony
metastasis (M1) in the pelvis which were further conﬁrmed
by bone scan.
Table 3 Pathologic characteristics of
patients with prostate carcinomas.
T stage No.
T1 2
T2 8
T3a 3
T3b 4
T4 3
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DWI appears to hold promise as a non-invasive imaging
modality in the detection of early microstructural and func-
tional changes of different organs (9). It depicts differences
in molecular diffusion caused by the random and microscopic
motion of molecules, which is known as Brownian motion
(11). In tumors, the motion of water is restricted, due to their
higher cellular density and increased nucleocytoplasmic ratio,
and it can be depicted on ADC maps, permitting a quantitative
evaluation (9).
DW-MRI is feasible on the prostate and the calculation of
the ADC values is relatively straightforward. In the prostate
tissue, the predominant contribution of the extracellular com-
ponent is from tubular structures and their ﬂuid content,
whereas the intracellular component is determined by the epi-
thelial and stromal cell (9).
In most cases, the PZ can be easily discriminated from the
CG, because it displays relatively higher ADC values com-
pared with the PZ (12,13). The CG consists of more compact
smooth muscle cells and sparser glandular elements than the
PZ, leading to a lower extracellular-to-intracellular ﬂuid ratio
and to lower ADC values (14,15).
To optimize the ability of DW imaging to allow character-
ization of the diffusion properties of tissue, imaging parame-
ters should be optimized according to the imaging unit and
magnetic ﬁeld strength used. Selection of the correct b value
is particularly important for prostate tissue with a prolonged
T2 relaxation time. Use of high b values increases diffusion
sensitivity by diminishing the hyperintensity of tissues with
long T2 relaxation times (thus avoiding T2 shine-through).
In general, a high b value (>700 s/mm2 at 1.5 T and
>1000 s/mm2 at 3 T) is recommended for prostate diffusion-
weighted imaging (16).
This study was conducted with b value (300, 500 and 800 s/
mm2). The high b values were used to obtain good quality
images. An image of low b-value (0–300 s/mm2) has higher
SNR, less distortion, but less diffusion weighting. Conversely,
high b-factor (800 s/mm2) images have more diffusion weight-
ing but suffer from low signal-to-noise ratio and severe image
distortion. Similar b values were used in the previous reports of
Ren et al. (2) and Yoshimitsu et al. (17).
Diffusion-weighted imaging and ADC have become power-
ful indicators for characterization of prostatic tissue, particu-
larly in differentiation between benign and malignant lesions
(18). Prostate carcinoma is histologically characterized by a
higher cellular density than normal prostate tissue, with
replacement of the normal glandular tissue; thus, it is expected
to show a more impeded diffusion of water molecules, com-
pared with normal prostatic gland (9).In this study we have found ADC values of the normal PZ,
CG, BPH and PCa similar to those reported in the literature.
The mean ADC value for normal PZ and CG was
1.839 ± 0.233 · 103 mm2/s, and 1.469 ± 0.2391 · 103
mm2/s respectively. This was in line with the study performed
by Tamada et al. (13) who have reported that the mean ADC
value of the normal PZ was 1.8 ± 0.27 · 103 mm2/s, normal
CG was 1.34 ± 0.14 · 103. Ren et al. (2) have also reported
that mean ADC values of normal PZ and CG were
1.829 ± 0.071 · 103 and 1.352 ± 0.052 · 103 mm2/s respec-
tively (2). Liu et al. reported ADC values of normal PZ and
CG were 1.69 ± 0.28 · 103, 1.36 ± 0.12 · 103 mm2/s
respectively (19).
The mean ADC value of benign prostatic hyperplasia was
1.359 ± 0.201 · 103 mm2/s. This result was in line with that
of Lu et al. who reported a mean ADC value for 28 cases of
BPH 1.21 ± 0.21 · 103 mm2/s. However this was slightly
lower than the value previously reported by Ren et al. (2) for
29 cases of BPH 1.576 ± 0.099 · 103 mm2/s.
The ADC value of BPH was signiﬁcantly lower than that of
normal CG. This was in agreement with the previous results of
Liu et al. (19). This can be due to CG tissue in patients with
BPH may contain more stroma tissue and concomitantly less
glandular components than healthy CG tissue (20).
The mean ADC value for prostatic carcinoma was
0.87 ± 0.13 · 103 mm2/s. This was in agreement with previ-
ous results of Ren et al. who reported that a mean ADC value
for 21 patients of prostatic carcinoma was 0.934 ±
0.166 · 103 mm2/s (2). In another study Tanimoto A et al.
have reported that mean ADC value of PCa was
0.93 ± 0.11 · 103 mm2/s (21). However it was slightly lower
than the value previously reported by Kilickesmez et al. (10)
who found the mean ADC value of 9 Pca patients was
1.06 ± 0.17 · 103 mm2/s. It was also lower than the value
of Tamada et al. (13) who reported a mean ADC value of
1.02 ± 0.25 · 103 mm2/s. Conversely it was slightly higher
than the value previously reported by Abdel-Maboud et al.
(22) who found that mean ADC value of 31 cases of PCa
was 0.737 ± 0.154 · 103 mm2/s.
Kılıc¸kesmez et al. (10) previously stated that the variation
in the reported ADC values of normal PZ, CG of the prostate
gland, and PCa may be related to the strength of the diffusion
gradient (300–1000 s/mm2), and the magnetic ﬁeld (1.5 or 3 T)
used.
There was a signiﬁcant difference between the ADC mea-
surement of benign and malignant prostatic lesions with a q
value <0.05. This was in agreement with the previous reports
of Yagci et al. (23), Tamada et al. (13) and Kilickesmez et al.
(10). This was in concordance with the results of Ren and his
colleagues (2] who have found a statistically signiﬁcant differ-
ence in the mean ADC values for the normal CG, PZ, prostate
cyst, BPH nodules and PCa foci with q values <0.05.
Kim and his colleagues (24) previously reported that even
with high b values, the overlap of the ADC values between
cancer and benign prostatic tissue limits the accuracy of
DWI in cancer detection, particularly in the transitional zone
tissue, due to its lower ADC compared to the peripheral zone
tissue. Akgun et al. (25) have stated that with any b value, the
assessment of the diffusion restriction should only be per-
formed as a part of routine multiparametric radiologic evalu-
ation of the prostate gland. In addition, in lesions with small
diameters, they suggest evaluating the diffusion restriction by
DWI and ADC measurement in prostate carcinoma 541a visual assessment of ADC maps instead of measuring ADC
values, which can be challenging. (25).
In the present study, although the mean ADC values of
prostate cancer DWI were signiﬁcantly lower than those of be-
nign prostatic tissues and BPH, considerable overlaps were
found between the cancer and benign prostatic tissues. There-
fore, we suppose that the use of ADC values alone could result
in the misdiagnosis of prostate cancer.
We compared the performance of T2 weighted MRI alone
versus T2 combined with DWI in localization of PCa. We have
found that the use of combined T2WI and DWI was able to
localize PCa better than T2 WI alone.
The accuracy, sensitivity and speciﬁcity for combined T2
with DWI were 90%, 85% and 95% respectively compared
to 77.5%, 65% and 90% when using T2 alone. Our results
were in concordance with those of the previous study of Yagci
et al. (23) who have reported a better performance of T2 com-
bined with DWI compared to T2 alone in prostate cancer
localization, with an accuracy of 89% vs 76%, speciﬁcity of
92% vs 77% and sensitivity of 81% vs 71%. Haider et al.
(7) have reported accuracy, sensitivity, and speciﬁcity of com-
bined T2 and diffusion 83%, 81% and 91% compared with
77%, 54% and 84% when using T2 alone.
6. The study has few limitations
The use of pelvic phased array coil resulted in less SNR in the
area of the prostate and poor image quality, however the use
of high ﬁeld strengths and higher b-values can improve lesion
detection. In addition not allMRI ﬁndings comparedwith path-
ological results after prostatectomy, with some pathological re-
sults were based onTRUS-guided biopsy, and it should be noted
that someTRUS-guided biopsiesmay give false negative results.
6.1. In conclusion
DWI appearance and ADC values can differentiate between
PCa and BPH. For localization of PCa the combined use of
T2 and DWI was better than using T2 alone. So, DWI with
ADC measurement can be used as a complementary imaging
method to conventional MRI in diagnosis of prostatic carci-
noma and benign prostatic hyperplasia.
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